Isolation and structure elucidation of photodegradation products of fexofenadine

Journal of Pharmaceutical and Biomedical Analysis

Volumn 46, Issue 2, 2008, Pages 250-257

  Breier, Ana Rita ^a   Nudelman, Norma Sbarbati ^b   Steppe, Martin ^a   Schapoval, Elfrides Eva Scherman ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Fexofenadine hydrochloride; Fexofenadine photodegradation products; Fexofenadine photostability; Photodegradation; Quality control

Indexed keywords

AROMATIC COMPOUND; BENZOPHENONE; CROSCARMELLOSE SODIUM; EXCIPIENT; FEXOFENADINE; HYDROXYPROPYLMETHYLCELLULOSE; IRON OXIDE; MACROGOL; MAGNESIUM STEARATE; MICROCRYSTALLINE CELLULOSE; POVIDONE; SILICON DIOXIDE; STARCH; TITANIUM DIOXIDE;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; DECARBOXYLATION; DRUG ISOLATION; DRUG STABILITY; DRUG STORAGE; DRUG STRUCTURE; HETERONUCLEAR MULTIPLE BOND CORRELATION; HETERONUCLEAR SINGLE QUANTUM COHERENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; OXIDATION; PHOTODEGRADATION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; QUALITY CONTROL; STRESS; THIN LAYER CHROMATOGRAPHY;

HISTAMINE H1 ANTAGONISTS; MOLECULAR STRUCTURE; PHOTOCHEMISTRY; SPECTROPHOTOMETRY, ULTRAVIOLET; TERFENADINE;

EID: 37749020310     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2007.09.017     Document Type: Article

References (34)

1. The Merck Index, an Encyclopedia of Chemicals, Drugs, and Biologicals, Merck & Co., Inc., Whitehouse Station, NJ, 2001.
2. Simpson K., and Jarvis B. Drugs 59 (2000) 301-321
3. Markham A., and Wagstaff A.J. Drugs 55 (1998) 269-274
4. Amichai B., Grunwald M.H., and Brenner L. Isr. Med. Assoc. J. 3 (2001) 207-209
5. Estelle F., and Simons R. In: Kaplan A.P. (Ed). Allergy. 2 ed. (2002), W.B. Saunders Company, Philadelphia 834-863
6. Borade P.S., Ballary C.C., Currie G.P., and Lee D.K.S. Drug Discov. Today: Ther. Strateg. 3 (2006) 253-259
7. Kawashima M., and Harada S. J. Dermatol. 34 (2007) 9-16
8. Howarth P.H. Clin. Exp. Allergy 2 (2002) 18-25
9. Hofmann U., Seiler M., Drescher S., and Fromm M.F. J. Chromatogr. B 766 (2002) 227-233
10. Gergov M., Robson J.N., Ojanperä I., Heinonen O.P., and Vuori E. Forensic Sci. Int. 121 (2001) 108-115
11. Fu I., Woolf E.J., and Matuszewski B.K. J. Pharm. Biomed. Anal. 35 (2004) 837-846
12. Nirogi R.V., Kandikere V.N., Shukla M., Mudigonda K., Maurya S., and Komarneni P. Biomed. Chromatogr. 21 (2007) 209-216
13. Uno T., Yasui-Furukori N., Takahata T., Sugawara K., and Tateishi T. J. Pharm. Biomed. Anal. 35 (2004) 937-942
14. Miura M., Uno T., Tateishi T., and Suzuki T. J. Pharm. Biomed. Anal. 43 (2007) 741-745
15. Gazy A.A., Mahgoub H., El-Yazbi F.A., El-Sayed M.A., and Youssef R.M. J. Pharm. Biomed. Anal. 30 (2002) 859-867
16. Radhakrishna T., and Reddy G.O. J. Pharm. Biomed. Anal. 24 (2002) 755-767
17. Breier A.R., Menegola J., Paim C.S., Steppe M., and Schapoval E.E.S. J. AOAC Int. 87 (2004) 1093-1097
18. Breier A.R., Garcia S.S., Jablonski A., Steppe M., and Schapoval E.E.S. J. AOAC Int. 88 (2005) 1059-1063
19. Mikus P., Valásková I., and Havránek E. Drug Dev. Ind. Pharm. 31 (2005) 795-801
20. Breier A.R., Paim C.S., Steppe M., and Schapoval E.E.S. J. Pharm. Pharm. Sci. 8 (2005) 289-298
21. Walker T.A., and Schmitt G.L. J. Liquid Chromatogr. Relat. Technol. 2 (2006) 25-43
22. ICH International Conference on Harmonisation of Technical requirements for registration of pharmaceuticals for human use, Photostability testing of new drug substances and products, 1996, 1-8.
23. ICH International Conference on Harmonisation of Technical requirements for registration of pharmaceuticals for human use, Stability testing of new drug substances and products, 2000, 1-17.
24. Valvini S.C. In: Carstensen J.T., and Rhodes C.T. (Eds). Drug stability, Principles and Practices. 3rd ed. (2000), Marcel Dekker, New York 515-552
25. Breier A.R., Steppe M., and Schapoval E.E.S. Chromatographia 64 (2006) 725-729
26. Nudelman N.S., and Cabrera C.G. J. Pharm. Sci. 91 (2002) 1274-1285
27. Tonnesen H.H. In: Tonnesen H.H. (Ed). Photostability of Drugs and Drug Formulations (1996), Taylor & Francis, London 1-7
28. Kommanaboyina B., and Rhodes C.T. Drug Dev. Ind. Pharm. 25 (1999) 857-868
29. Food and Drug Administration, Guidance for industry: stability testing of drug substances and drug product, draft guidance, June, 1998.
30. Tonnesen H.H. Int. J. Pharm. 225 (2001) 1-14
31. Moore D.E. In: Tonnesen H.H. (Ed). Photostability of Drugs and Drug Formulations (1996), Taylor & Francis, London 63-82
32. Pretsch E., Bühlmann P., and Affolter C. Structure Determination of Organic Compounds (2000), Springer, New York pp. 1-243
33. Breitmaier E. Structure Elucidation by NMR in Organic Chemistry: A Practical Guide (1993), John Wiley & Sons, Chichester pp. 71-259
34. In: Moffat A.C. (Ed). Clarke's Analysis of Drugs and Poisons in Pharmaceuticals, Body Fluids and Postmortem Material (2004), Pharmaceutical Press, London 1033-1034